Saturday 26 – Sunday 27 June 2021, virtually
Thank you to everyone who attended the IHCAN Summit 2021
Now virtual for 2021!
What is the IHCAN Summit?
Back for 2021, this CPD accredited event is a must-attend for registered nutritional therapists, integrative health practitioners and complementary and alternative medicine (CAM) professionals.
Organised by the team behind the IHCAN Conferences and IHCAN magazine (previously the CAM Conferences and CAM magazine), the IHCAN Summit features the same, industry-leading, innovative education you are used to but on a bigger scale, and this year – VIRTUALLY, wherever you are.
With the continued aim of bringing you the latest insights and research on the most up-to-date topics within the industry, this year’s IHCAN Summit features five+ incredible speakers over two days, each focusing on their specialist subjects.
How does it work?
We’re using a bespoke virtual conference and expo platform – you don’t need to download any additional software and it will work on every device.
We’ll send you access details two weeks before the event.
To download the copy schedule, click here.
We’ve invited speakers from around the world to join us at this year’s IHCAN Summit, including:
The headline speakers
Dr Richard Feinman
Richard Feinman is Professor of Cell Biology (Biochemistry) at the State University of New York (SUNY) Downstate Medical Center in Brooklyn, New York.
‘The medical literature. What’s really wrong and how can we fix it’
A paradoxical feature of the current medical literature is the increasing number of publications criticizing that literature as unreliable, not reproducible or simply wrong. Medical nutrition may be most problematical, and the status of low-carbohydrate and ketogenic diets, the extreme example. I will use a single example, a paper by Seidelmann and coworkers [Lancet Public Health 2018; 3: e419–428], to illustrate the breach of scientific standards and the need for greater transparency and for an improved system of peer review.
Beyond traditional scientific principles, I will invoke Bradford Hill’s criteria and discuss the concept of evidence-based-medicine by analogy with evidence in courts of law. (Who decides admissibility?) Seidelmann, et al. concluded that low-carbohydrate diets were associated with an increased risk of all-cause mortality. The conclusion is surprising on the face of it. While often criticized, such diets are widely used with no documented harm, and have continued to demonstrate success in clinical and experimental studies. The strongest of these contradictory studies are not cited.
- Learning point: By analogy with a court of law, exculpatory evidence must be cited. The best evidence. Courts have ruled, for example, that the police cannot look the other way.
Seidelmann, et al. recognize low-carbohydrate diets as a specific intervention but no diets were studied. The paper is a retrospective analysis of nutrient intake in study of heart disease. No researcher in the field would say that the paper had received peer review.
- Learning point: Editors must recognize controversial subjects and appoint reviewers from both sides of the controversy. To fail to do so constitutes de facto bias.
Whatever the appropriateness of the study, the hazard ratios (analogous to relative risk) are distinctly small, typically 1.2, suggesting little reliability.
- Learning point: Bradford Hill’s criteria for when an associational study supports causation must be addressed and, in particular, “first on my list,” the size of the association.
These and other points will be discussed and solutions proposed.
About Dr Richard Feinman
Richard Feinman is Professor of Cell Biology (Biochemistry) at the State University of New York (SUNY) Downstate Medical Center in Brooklyn, New York. Dr. Feinman’s original area of research was in protein chemistry and enzyme mechanism, particularly in blood coagulation and related processes. His current interest is in nutrition and metabolism, specifically in the area of the application of ketogenic diets for cancer. Dr. Feinman is the founder and former co-Editor-In-Chief (2004-2009) of the journal, Nutrition&Metabolism.
Richard Feinman is principal author of the 26-author comprehensive review “Dietary carbohydrate restriction as the first approach in diabetes management: Critical review and evidence base. His recent book Nutrition in Crisis was voted in top 3 books on health and fitness by Forbes and describes the current state of medical nutrition, the underlying science and the flaws and limitations and what we can do about.
Dr. Feinman received his BA from the University of Rochester and he holds a PhD in chemistry from the University of Oregon.
Dr Cheryl Burdette
Cheryl Burdette, ND, received her Doctor of Naturopathy degree from Bastyr University in 2001. She completed her residency at Cancer Treatment Centers of America. Dr. Burdette is currently in private practice in Atlanta, Georgia at Progressive Medical Center, one of the largest Integrative Medicine clinics in the Southeast.
‘LPS and Autoimmunity; A Meaningful and Modifiable Marker’
Our understanding of immunotolerance and autoimmunity, through gut based exposure, has grown exponentially over the years. This broadened understanding of gut based immune priming elucidates new targets for immune regulation in autoimmune conditions. As our understanding of the microbiome increases, we can understand the mechanisms that skew and support immune tolerance and T-cell differentiation. A key regulator in many autoimmune conditions includes the interaction between LipoPolySaccharide (LPS), a bacterial endotoxin, and Treg cells. Although LPS is ubiquitous to Gram-negative bacteria, and created by several commensal bacterial Genera, immune regulation to LPS also involves the interaction of Gram-positive flora such as Bifidobacter. These interactions will determine programming of naïve T-cells and influence the balance of the immune response. LPS, even more so than the bacteria that make it, is uniquely able to trigger an autoimmune process by many mechanisms. LPS is associated with Toll-Like Receptor (TLR) differentiation that is pathognomonic for certain autoimmune conditions, demonstrating its pivotal relationship. LPS is also able to decrease Treg function, a hallmark of autoimmunity, thus allowing immune function to proceed stimulated and unregulated. An understanding of LPS and its activity in immune function increases our clinical understanding and management of autoimmune conditions such as Rheumatoid arthritis, and Crohn’s Disease, to name a few.
1) We will examine the role of LPS and cell signaling in determining TLR expression.
2) Understand the relationship between LPS and Treg cells as they relate to autoimmunity.
3) Examine clinical interventions that disrupt LPS interaction with Treg cells and improving their function.
About Dr Cheryl Burdette
Cheryl Burdette, ND, received her Doctor of Naturopathy degree from Bastyr University in 2001. She completed her residency at Cancer Treatment Centers of America. Dr. Burdette is currently in private practice in Atlanta, Georgia at Progressive Medical Center, one of the largest Integrative Medicine clinics in the Southeast. She is the director of a naturopathic residency program with a focus in nutritional biochemistry. She serves on an IRB board and reviews studies related to complementary and alternative therapies. Dr. Burdette is one of the authors of the book, “Laboratory Evaluations in Molecular Medicine” and has published in many journals including Alternative Medicine Review and Clinical Chemistry. She is an often-sought speaker and is invited to present at Grand Rounds at all of the Naturopathic medical schools as well as educational events for M.D.s, D.O.s and other allied healthcare practitioners. Dr. Cheryl Burdette has been a member of the BOA for an Inc 500 supplement company since 2009. She serves as a faculty member at University Bridgeport. She also teaches at the University of Miami, the first medical program to include integrative medicine in the core curriculum.
She is President and Education director of Dunwoody Labs. In this position she is involved in clinical trials of different nutritional products as well as development of functional testing profiles. Her marriage between clinical practice and laboratory oversight, gives her a unique perspective in evidence-based natural therapies, testing and research.
Dr Linda Isaacs
Dr Linda L. Isaacs, M.D., received her Bachelor of Science degree from the University of Kentucky, and her medical degree from Vanderbilt University School of Medicine. She is certified by the American Board of Internal Medicine, most recently completing recertification in 2019.
‘Enzymes and Cancer: lessons from 30 years of success’
In her lecture, Dr. Isaacs will review the rationale for the different aspects of this treatment method, including case reports from her and Dr. Gonzalez’ files.
- Understanding the role that pancreatic enzymes may play in the body’s surveillance mechanisms for cancer, including historical and modern support.
- Reviewing the evidence that diet and supplementation can affect the autonomic nervous system and thereby affect health.
- Describing the role of detoxification in this treatment protocol.
About Dr Linda Isaacs
Dr Linda L. Isaacs, M.D., received her Bachelor of Science degree from the University of Kentucky, and her medical degree from Vanderbilt University School of Medicine. She is certified by the American Board of Internal Medicine, most recently completing recertification in 2019.
For more than 25 years, Dr. Isaacs has offered a nutritional approach to patients diagnosed with various illnesses including cancer. The treatment involves large doses of pancreatic enzymes for cancer patients; individualized nutritional supplement protocols and diets, ranging from almost exclusively vegetarian to diets heavy in animal protein and fat; and various detoxification procedures that help the body rid itself of metabolic wastes.
In 1999, Dr. Isaacs and the late Dr. Nicholas Gonzalez (1947-2015) published the results of a research study on pancreatic cancer in the peer-reviewed journal Nutrition and Cancer, showing survival well beyond what is described in the medical literature. In 2007, they co-authored a series of case reports that appeared in the peer-reviewed journal Alternative Therapies in Health and Medicine (ATHM). In 2019, ATHM published an additional two case reports of patients that Dr. Isaacs treated. For more information about her and her work, visit www.drlindai.com.
Dr Dale Bredesen
Dr Dale E. Bredesen, MD, is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer’s disease. He graduated from Caltech then earned his MD from Duke University Medical Center in Durham, North Carolina.
‘COVID-19 and Alzheimer’s: the surprising parallels and critical differences in 2 pandemics’
The COVID-19 pandemic has killed over 600,000 people in the US; for perspective, Alzheimer’s will kill over 70 times that many of the currently living Americans. There are key parallels in these 2 pandemics, such as the immune dysregulation and many risk factors. However, there are also critical differences, such as the lack of a vaccine for Alzheimer’s and the lack of agreement on etiology. Prof. Dale Bredesen, author of The End of Alzheimer’s, will discuss how each of these 2 pandemics offers us insight into the other.
About Dr Dale Bredesen
Dr Dale E. Bredesen, MD, is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer’s disease. He graduated from Caltech then earned his MD from Duke University Medical Center in Durham, North Carolina. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel Laureate Stanley Prusiner’s laboratory at UCSF as a National Institutes of Health postdoctoral fellow. He has held faculty positions at UCSF; the University of California, Los Angeles; and the University of California, San Diego. Dr Bredesen directed the Program on Aging at the Burnham Institute before coming to the Buck Institute in 1998 as its founding president and CEO.
Catalina Fernández de Ana Portela is a biologist expert in Mycology and founder of Hifas da Terra. She has built a life and business around the beneficial properties of medicinal mushrooms studying their composition and creating innovative products.
‘Medicinal mushrooms as powerful immunomodulators in clinical practice’
Immunomodulation encompasses all therapeutic interventions aimed at modifying the immune response. Medicinal mushrooms have been valued as food and health supplements for centuries. Thanks to the identification of their bioactive molecules, we find that many of them show a strong immunomodulatory activity, including a prebiotic effect via gut microbiota regulation. Scientific evidence supports the use of medicinal mushrooms as powerful immunomodulators that can be safely used as adjuvants in clinical practice for effectively helping patients with immunomodulatory imbalances.
- Understand how medicinal mushrooms can help in immunomodulatory alterations: prevention of infection in immunodeficiency states, fighting established infections, as anticancer agents, suppression of allergies and keeping autoimmune diseases under control
- Learn the main bioactive compounds of medicinal mushrooms with immunomodulatory activities
- Discover the current status of clinical and preclinical studies on the immunoregulatory effects of medicinal mushrooms
About Catalina Fernández de Ana Portela
Catalina Fernández de Ana Portela is a biologist expert in Mycology and founder of Hifas da Terra. She has built a life and business around the beneficial properties of medicinal mushrooms studying their composition and creating innovative products. It is her ambition to create awareness of the healing properties of mushrooms on our well- being. Her continuous investigations further confirmed these living organisms to be powerful adaptogens capable of regulating the immune system and protecting the body from a large variety of diseases and health issues.
Catalina has been presented with a number of awards for her remarkable work and visionary approach by creating biotech products of high added value from a natural resource: mushrooms.
Kara Fitzgerald, ND
Dr. Fitzgerald is the lead author and editor of Case Studies in Integrative and Functional Medicine and is a contributing author to Laboratory Evaluations for Integrative and Functional Medicine and the Institute for Functional Medicine (IFM)’s Textbook for Functional Medicine
‘Effects of a Diet & Lifestyle Intervention on Biological Aging First-of-its-kind human clinical trial (pilot study)’
8-week intervention takes 3 years off biological age: IFM’s Kara Fitzgerald talks us through her brand-new study showing the power of a methylation-angled lifestyle and diet intervention.
The groundbreaking clinical trial shows that biological age – as measured by the DNAmAge epigenetic clock – can be reduced significantly by following a diet and lifestyle program that aims to balance DNA methylation:
Manipulations to slow biological aging and extend healthspan are of interest given the societal and healthcare costs of our aging population. Herein we report on a randomized controlled clinical trial conducted among 43 healthy adult males between the ages of 50-72. The 8-week treatment program included diet, sleep, exercise and relaxation guidance, and supplemental probiotics and phytonutrients. The control group received no intervention. Genome-wide DNA methylation analysis was conducted on saliva samples using the Illumina Methylation Epic Array and DNAmAge was calculated using the online Horvath DNAmAge clock (2013). The diet and lifestyle treatment was associated with a 3.23 years decrease in DNAmAge compared with controls (p=0.018). DNAmAge of those in the treatment group decreased by an average 1.96 years by the end of the program compared to the same individuals at the beginning with a strong trend towards significance (p=0.066). Changes in blood biomarkers were significant for mean serum 5-methyltetrahydrofolate (+15%, p=0.004) and mean triglycerides (-25%, p=0.009). To our knowledge, this is the first randomized controlled study to suggest that specific diet and lifestyle interventions may reverse Horvath DNAmAge (2013) epigenetic aging in healthy adult males. Larger-scale and longer duration clinical trials are needed to confirm these findings, as well as investigation in other human populations.
About Kara Fitzgerald, N.D
Kara Fitzgerald, ND, received her doctor of naturopathic medicine degree from the National University of Natural Medicine in Portland, Oregon. She completed the first Counsel on Naturopathic Medicine-accredited post-doctorate position in nutritional biochemistry and laboratory science at Metametrix Clinical Laboratory (now Genova Diagnostics) under the direction of Richard Lord, PhD. Her residency was completed at Progressive Medical Center, a large, integrative medical practice in Atlanta, Georgia.
Dr. Fitzgerald is the lead author and editor of Case Studies in Integrative and Functional Medicine and is a contributing author to Laboratory Evaluations for Integrative and Functional Medicine and the Institute for Functional Medicine (IFM)’s Textbook for Functional Medicine. With the Helfgott Research Institute, Dr. Fitzgerald is actively engaged in clinical research on the DNA methylome using a diet and lifestyle intervention developed in her practice. The first publication from the study focuses on reversal of biological aging and was published 04-12-2021 in the journal Aging. A consumer book and application-based program with DNA methylation assessment are scheduled for release 01-2022.
Dr. Fitzgerald is on the faculty at IFM, is an IFM Certified Practitioner and lectures globally on functional medicine. She runs a Functional Medicine Clinic Immersion program for professionals, and maintains a podcast series, New Frontiers in Functional Medicine and an active blog on her website, www.drkarafitzgerald.com. Her clinical practice is in Sandy Hook, Connecticut.
I also authored or co-authored two peer reviewed papers about SARS-CoV2
Fitzgerald K. Furin protease: From SARS CoV-2 to anthrax, diabetes, and hypertension. Perm J 2020;24:20.187. DOI: https://doi.org/10.7812/TPP/20.187.
Yanuck SF, Pizzorno J, Messier H, Fitzgerald KN. Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery. Integr Med (Encinitas). 2020;19(Suppl 1):8-35.
The breakout sessions
A selection of smaller breakout sessions – in a traditional webinar style – on a variety of topics. Take your pick! Don’t worry if you want to attend more than one – we’ll send you the recordings from every session after the event.
'Managing the symptoms of Chemotherapy-induced peripheral neuropathy in the cancer patient (CIPN)' Daniel Baden ND
Chemotherapy-induced peripheral neuropathy (CIPN) is a common and disabling side effect of chemotherapy for which there is no established effective treatment. The development of CIPN may require chemotherapy dose reduction or cessation, which can increase cancer-related morbidity and mortality. It has a complex, poorly understood pathophysiology, with changes in the structure and function of peripheral motor, sensory and autonomic neurons causing pain, sensory changes and weakness. CIPN occurs in as many as 68% of patients within the first month of chemotherapy treatment and can last many years after discontinuation of treatment and reduce the quality of life of cancer survivors. Therefore, the preventive and therapeutic strategies for CINP are an urgent need.
Palmitoylethanolamide (PEA) is an endogenous fatty acid amide that is emerging as a promising treatment for CIPN. PEA has anti-inflammatory, antinociceptive, and neuroprotective properties and is synthesised on demand in response to inflammatory and pain-related processes. Clinical research reveals that treatment with exogenous PEA is effective and safe in various neuropathological conditions, including diabetic neuropathy, nerve compression syndromes and chemotherapy-induced neuropathic pain. Given the prevalence of cancer and, subsequently, CIPN is increasing, with more and more survivors left with long-term functional disability and reduced quality of life, finding neuroprotective interventions such as PEA is of utmost importance.
About the speaker, Daniel Baden ND, Co-founder and Director Innovation of BioMedica Nutraceuticals
Daniel Baden is a Naturopath and Homoeopath and the co-founder of BioMedica Nutraceuticals. Beginning his journey in clinical practice, he has assumed many roles over the last 3 decades including lecturing and consultancy to various groups across industry and profession. He is currently serving on the board of Complementary Medicines Australia as Chair, Practitioner committee. Daniel has enjoyed several media engagements as the ‘expert Naturopath.’ His extensive experience and interest in ongoing practitioner education, ensures his seminars are an empowering and worthwhile experience for all attendees. Overall, his career is focussed on making professional natural medicine more available to the community at large.
'The microbiota & ageing – A paradigm shift in healthy long life' Dr Kim Bretz ND
There’s a huge difference between living a long life and dying a long life. While healthcare systems have had a huge focus on increasing longevity, healthy aging is a missing factor for many people. And one of the largest factors to living a long, healthy life is having a healthy & diverse microbiota.
Your discussion will involve new research in what a healthy aged microbiota looks like, inflammaging and how stress relates to dysbiosis.
About the speaker, Dr. Kim Bretz ND
Dr. Kim Bretz ND is a naturopathic doctor working and living in Waterloo Region in Canada. She is a speaker, consultant and adjunct faculty at the University of Waterloo, Pharmacy.
She is a passionate international public speaker, having presented to multiple corporations and agencies, and is a guest lecturer for Canadian universities in the areas of health promotion, function foods and natural health care products. For 6 years, Kim was part of Human Nature Network, a nationally syndicated radio program though CHUM radio, speaking in the areas of women’s health. She also runs continuing education for healthcare professionals in the area of the microbiota, strain specific probiotics and gastrointestinal health and has a new practitioner program, The Gut Health Incubator to help healthcare providers niche into the area of gut health.
She has spoken and consulted for numerous companies including in lab supplement and pharmaceutical and was the clinical lead in a research trial through the University of Guelph with the Spagnuolo Research Lab.
'Breath tests for IBS – useful or useless?' Jordan Haworth
Breath testing is a diagnostic tool used by many healthcare practitioners, but the use of breath testing in digestive disorders, such as IBS and gastroparesis, is controversial. Here we will explore the types of breath tests available and whether they can help to diagnose and treat common gastrointestinal issues.
About the speaker, Jordan Haworth
Jordan Haworth is a gastrointestinal physiologist who specialises in a range of diagnostic investigations for gut disorders. Jordan regularly contributes to research and has published in scientific journals with a keen interest in gastroesophageal reflux disease, disorders of gut-brain interaction and the gut microbiome.
‘The Energy Equation’ Chris Newbold Nutritional Therapist BSc, DipCHEd Nut
We have evolved a complex biological toolkit to enable us to engage appropriately with our environment and the demands placed on us. We experience this as how energetic we feel. Disrupted energy metabolism affects many people and is often at the heart of chronic conditions. Looking at blood glucose, AHPA function, thyroid and mitochondrial health, Chris Newbold presents a practical model of energy homeostasis and allostasis. He will focus in particular on the interaction between the nervous and endocrine systems, and the nutritional solutions you need to support your clients.
About the speaker, Chris Newbold Nutritional Therapist BSc, DipCHEd Nut
Chris is a nutritional therapist and lecturer with over 16 years’ experience, who worked in the NHS before moving to natural therapies. Utilising his wide variety of healthcare experience, he ran a busy clinic in Birmingham, practising naturopathic, holistic nutrition with clients with a range of complex disorders before starting work for BioCare as a technical advisor in 2006. He is now Head of Nutrition Strategy, developing innovative nutrition concepts, new products, and BioCare’s extensive education programme.
'Mitochondrial Support: Is Ubiquinol the New Center of the Medical Universe?' Decker Weis, NMD FASA
Dr. Decker Weiss, an American Cardiologist, discusses the research and clinical application for multiple conditions (including coronary artery disease and heart failure) for the active form of CoQ10.
About the speaker, Decker Weis, NMD FASA
Dr. Decker Weiss is the first “Naturopathic Physician” to complete a conventional internship, residency, and fellowship in cardiology. He trained in the Columbia Hospital system, the Arizona Heart Hospital, and the prestigious Arizona Heart hospital. Dr. Weiss was on staff of the Arizona Heart Hospital for ten years, while launching the Weiss Center for Health and Medicine. Dr. Weiss is considered an expert in reducing the need for angioplasty, bypass surgery, and ablations, while moving people safely to less pharmaceuticals and more vitality. Dr. Weiss brings 20 years of experience to the table to educate practitioners and the public, and has performed over 1000 lectures through the years.
'Probiotics in practice – Which strains to recommend for histamine intolerance, hay fever, GORD and more' Sarah Oboh, BSc (Hons) Nutrition
About the speaker, Sarah Oboh, BSc (Hons) Nutrition
For over 11 years, Sarah has worked within the healthcare industry. Driven by her passion for transformative nutrition, she began her career as a Nutritionist in private and public health. With a keen interest in complementary and alternative medicine (CAM), she decided to pursue a role at OptiBac Probiotics, where she supports CAM practitioners in their recommendation of probiotics in practice.
‘Support for Viral, Parasitic, Fungal and Bacterial Infections: Natural Therapies with Rio Health’ Rose Holmes, BSc (Hons), Dip.ION, PGCE, mBANT, CNHC
As specialists in South American botanicals for the past 34 years, Rio Health will provide information about how these amazing botanical ingredients can support immune health as well as the health of the gallbladder, and respiratory, gastrointestinal and cardiovascular systems. Better understanding of the multiple therapeutic potential of botanicals means these can be ideally suited for clients who present with several health issues.
New research will be presented alongside suggestions for use in immune support protocols and protocols to address a wide range of health conditions including respiratory infections, brain fog, Lyme disease, toxic load, biofilm, joint pain, Candida overgrowth, neurodegeneration, hormone imbalance and blood sugar regulation.
About the speaker, Rose Holmes, BSc (Hons), Dip.ION, PGCE, mBANT, CNHC
Rose Holmes, BSc (Hons), Dip.ION, PGCE, mBANT, CNHC is a Registered Nutritional Therapist with a special interest in chronic illness, circadian rhythm disruption and healthy ageing. She is the Education and Training Manager at Rio Health and provides training to other practitioners and health professionals on natural therapies.
‘Probiotics for the Management of UTI’ Dr Richard Day, MA (Oxon), MBBS, MRCPsych
About the speaker, Dr Richard Day, MA (Oxon), MBBS, MRCPsych
Richard is Medical Director for ADM Protexin, manufacturers of popular live bacteria brands Bio-Kult and Lepicol. In this role he is responsible for the design and delivery of all clinical research across the Health & Wellness business, with a particular focus on microbiome solutions. He works in collaboration with many of the world’s leading Universities and academic research institutions, forming partnerships to deliver innovative research. Richard is also ADM’s representative on multiple international scientific bodies, including the International Life Sciences Institute and the Pharmabiotic Research Institute.
Since joining ADM Protexin in 2018, Richard has worked on multiple research projects and clinical trials, including research into migraine, male fertility, infection prevention, Parkinson’s disease, anxiety and depression.
Richard is a medical doctor by training and holds degrees from the University of Oxford and King’s College London
Bio-Kult | Diamond Sponsor
BioMedica | Gold Sponsor
OptiBac | Gold Sponsor
College of Naturopathic Medicine
Institute for Optimum Nutrition
Green People Company
Hifas Da Terra UK
Natures Plus UK
Nutritional Therapists of Ireland
The Nutrition Network
BioCare® | Gold Sponsor
Functional Gut Diagnostics | Gold Sponsor
New Roots Herbal | Gold Sponsor
Integrative Healthcare & Applied Nutrition magazine
Good Health Naturally
Henry’s Health Hub
NNA (Naturopathic Nutrition Association)
“The IHCAN Virtual Event was an ambitious response to challenging times. It proved we can remain connected with colleagues, committed to learning, and resilient to adversity by achieving a really great event with the ‘buzz’ usually unique to a live experience.
The networking, quality of presentations and feeling of connectedness was refreshing. I was honoured to speak at and support the event
Benjamin I. Brown, ND., IHCAN Contributing Editor (feedback from our September 2020 Virtual Event)
“I thought the content of this conference was exceptional”
Source: Feedback form, IHCAN Conferences Virtual Event November 2020
Proudly sponsored by
Proudly supported by
Don’t hesitate to contact us:
Integrative Healthcare & Applied Nutrition (IHCAN) Summit
Target Publishing Ltd
The Old Dairy Hudsons Farm
Event Manager: Georgia Barnes – Georgia.Barnes@targetpublishing.com 01279 810080
Marketing: James Rix – James.Rix@targetpublishing.com 01279 810080
Sales Manager: Abigail Morris– Abigail.Morris@targetpublishing.com 01279 816300
Senior Sales Executive: Maria Francis – Maria.Francis@targetpublishing.com 01279 816300
Education Director: Simon Martin – Simon.Martin@targetpublishing.com 01279 810080
The IHCAN Summit is organised by Target Publishing Ltd.
Target Publishing Limited is the leading publisher and conference organiser serving the natural, complementary health markets, leisure, education, sport and eco markets. Target Publishing’s ethos has remained the same since its formation in July 2000 – to provide high quality publications, shows and events for the markets it serves. Education and innovation are the cornerstones of the company’s approach. The Target Publishing team has a wealth of experience and knowledge and their dynamic approach to publishing and conferences brings fresh ideas to the natural product, CAM, eco, organic, sport, fine food and outdoor pursuits sectors.
If you would like to request information on any of Target Publishing’s products please call 01279 816300 or click here.